Oryzon Genomics is a functional genomics company based in Barcelona. Launched in 2001 as a spin-off of the Spanish National Research Council (CSIC) and the University of Barcelona, it has an international staff of 30 highly qualified scientists.
Oryzon Genomics develops its own core genomics research program, principally in cereals, but also has ongoing projects in biomedicine niches in collaboration with academic groups and hospitals.
PALAU PHARMA is a newly created biopharmaceutical company, whose mission is the discovery and development of drug candidates for the treatment of chronic inflammatory conditions. The company is a spin-out from GRUPO URIACH’s R&D Department, and so it benefits from the advantage of its integration in a well established Group which has been in the pharmaceutical business for over 160 years, and which is leading Spanish pharmaceutical company when it comes to R&D productivity.
PALAU PHARMA has inherited Uriach’s former Management and Scientific team that has a proven track record in bringing molecules from is own drug discovery to final commercialization. Examples are the development of TRIFUSAL, FLUTRIMAZOLE and RUPATADINE.
Pol. Ind. Riera de Caldes
Av. Camí Reial 51-57
08184 Palau-solità i Plegamans
Tel: +34 93 864 96 92
Fax: +34 93 864 66 06